The results showed that the expression of eIF3i had the superior predictive efficiency compared with eIF3k expression, combined expression of eIF3i and eIF3k, WHO grade and subgroups of WHO 2016 for predicting survival of patients with 1p/19q non-codeletion glioma in the CGGA dataset (Fig. 2a, b). This evidence concerns the gene EIF3K and glioma.